At hubXchange’s European Antibody Therapeutics event, Debby Kruijsen will lead a round-table discussion entitled ‘Implementing discovery strategies to value the therapeutic potential of lead antibody candidates’ while Nienke Smits will present a poster entitled ‘DeepDisplay™: a powerful and unique human lead antibody discovery platform utilizing OmniMouse®’.
Taking place in Munich on 21 March, hubXchange’s event brings together executives from pharmaceutical and biotechnology to address and find solutions to the key issues faced in developing antibody therapeutics.
While attending this event, the ImmunoPrecise team will be participating in one-on-one meetings with current and potential clients.
Contact the company today to learn more about how the firm may help with your antibody discovery and protein engineering needs to accelerate your therapeutic pipeline.